UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 80.

Rehm, J; Weekes, J (2005). Abuse of controlled prescription drugs. In: CCSA. Substance Abuse in Canada: current challenges and choices. Ottawa: Canadian Centre on Substance Abuse, 30-37.

Fischer, B; Vasdev, S; Haydon, E; Baliunas, D; Rehm, J (2005). Acceptabilite d'un traitement du virus de l'hepatite C chez les utilisateurs de drogues injectables au Canada. La Presse Médicale, 34:1209-1212.

Rehm, J; Monteiro, M (2005). Alcohol consumption and burden of disease in the Americas: implications for alcohol policy. Revista Panamericana de Salud Pública, 18(4/5):241-248.

Rehm, J; Room, R; van den Brink, W; Jacobi, F (2005). Alcohol use disorders in EU countries and Norway: an overview of the epidemiology. European Neuropsychopharmacology, 15(4):377-388.

Rehm, J (2005). Alkoholkonsum, Gesamtmortalität und Morbidität. In: Singer, M V; Teyssen, S. Alkohol und Alkoholfolgekrankheiten. Grundlagen, Diagnostik, Therapie. 2., vollständig überarbeitete und aktualisierte Auflage. Berlin: Springer, 577-587.

Wild, C; El-Guebaly, N; Fischer, B; Brissette, S; Brochu, S; Bruneau, J; Noël, L; Rehm, J; Tyndall, M; Mun, P (2005). Comorbid Depression Among Untreated Illicit Opiate Users: Results From a Multisite Canadian Study. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie, 50(09):512-518.

Frei, A; Rehm, J (2005). Die Prävalenz psychischer Komorbidität unter Opiatabhängigen: eine Metaanalyse bisheriger Studien. In: Bundesamt für Gesundheit. Suchtforschung des BAG / Recherches de l'OFSP en matière de dépendances 1999-2001. Bern: Bundesamt für Gesundheit, 125-129.

Rehm, J (2005). Die Rolle von Bevölkerungsumfragen in modernen Monitoringsystemen für legale und illegale Drogen. Suchtforschung des BAG, 51:S4-S5.

Fischer, B; Rehm, J; Kim, G; Kirst, M (2005). Eyes wide shut? A conceptual and empirical critique of methadone maintenance treatment. European Addiction Research, 11(1):1-12.

Farley, J; Vasdev, S; Fischer, B; Haydon, E; Rehm, J; Farley, T A (2005). Feasibility and outcome of HCV treatment in a Canadian federal prison population. American Journal of Public Health, 95(10):1737-1739.

Farley, J; Vasdev, S; Fischer, B; Rehm, J (2005). Hepatitis C treatment in a Canadian federal correctional population: Preliminary feasibility and outcomes. International Journal of Prisoner Health, 1(1):13-18.

Rehm, J; Single, E; Fischer, B (2005). Heroin prescription and public health. Epidemiological considerations and the need for evidence-based cost-effective Interventions. In: Rihs-Middel, M; Hammig, R; Jacobshagen, N. Heroin-assisted treatment. Work in progress. Bern: Huber, 365-373.

Fischer, B; Rehm, J; Brissette, S; Brochu, S; Bruneau, J; El-Guebaly, N; Noël, L; Tyndall, M; Wild, C; Mun, P; Baliunas, D (2005). Illicit opioid use in Canada: Comparing social, health and drug use characteristics of untreated users in five cities (OPICAN study). Journal of Urban Health: Bulletin of the New York Academy of Medicine, 82(2):250-266.

Leri, F; Stewart, J; Fischer, B; Rehm, J; Brissette, S; Brochu, S; Bruneau, J; El-Guebaly, N; Noel, L; Tyndall, M; Wild, C (2005). Patterns of opioid and cocaine co-use: A descriptive study in a Canadian sample of untreated opioid-dependent individuals. Experimental and Clinical Psychopharmacology, 13(4):303-310.

Haydon, E; Rehm, J; Fischer, B; Monga, N; Adlaf, E (2005). Prescription drug abuse in Canada and the diversion of prescription drugs into the illicit drug market. Canadian Journal of Public Health. Revue Canadienne de Santé Publique, 96(6):459-461.

Rehm, J; Room, R; van den Brink, W; Kraus, L (2005). Problematic drug use and drug use disorders in EU countries and Norway: an overview of the epidemiology. European Neuropsychopharmacology, 15:389-397.

Rehm, J; Monga, N; Adlaf, E; Taylor, B; Bondy, S; Fallu, J S (2005). School matters: Drinking dimensions and their effects on alcohol related problems among Ontario Secondary School Students. Alcohol and Alcoholism, 40(6):569-574.

Rehm, J; Zhang, B; Bondy, S; Ashley, M; Cohen, J; Ferrence, R; Jain, M; Miller, A; Rohan, T (2005). The effect of smoking on the relationship between alcohol consumption and all-cause mortality in Canadian women. Contemporary Drug Problems, 32:373-386.

Rehm, J; Room, R (2005). The global burden of disease attributable to alcohol, tobacco and illicit drugs. In: Stockwell, T; Gruenewald, P; Toumbourou, T; Loxley, W. Preventing harmful substance use: the evidence base for policy and practise. Chichester: Wiley, 25-41.

Lerch, S; Hartwig, C; Rehm, J; Gschwend, P (2005). Unerwünschte Arzneimittelwirkungen in der heroingestützen Behandlung (HeGeBe) im Zusammenhang mit verschiedenen Applikationsformen in den Jahren 2001 und 2002 in der Schweiz. In: Bundesamt für Gesundheit. Suchtforschung des BAG / Recherches de l'OFSP en matière de dépendances. Bern: Bundesamt für Gesundheit, 71-79.

Rehm, J; Fischer, B; Graham, K; Haydon, E; Mann, R E; Room, R (2004). The importance of environmental modifiers of the relationship between substance use and harm. Open Addiction Journal, 99(6):663-666.

Prinzleve, M; Haasen, C; Zurhold, H; Matali, J L; Bruguera, E; Gerevich, J; Bácskai, E; Ryder, N; Butler, S; Manning, V; Gossop, M; Pezous, A; Verster, A; Camposeragna, A; Andersson, P; Olsson, B; Primorac, A; Fischer, G; Güttinger, F; Rehm, J; Krausz, M (2004). Cocaine use in Europe - a multi-centre study: patterns of use in different groups. European Addiction Research, 10(4):147-155.

Haasen, C; Prinzleve, M; Zurhold, H; Rehm, J; Güttinger, F; Fischer, G; Jagsch, R; Casas, M; Matali, J L; Krausz, M (2004). Cocaine use in Europe — a multi-centre study. European Addiction Research, 10(4):139-146.

Fischer, B; Brissette, S; Brochu, S; Bruneau, J; El-Guebaly, N; Noel, L; Rehm, J; Tyndall, M W; Wild, C; Mun, P; Haydon, E; Baliunas, D (2004). Determinants of overdose incidents among illicit opioid users in 5 Canadian cities. Canadian Medical Association Journal = Journal de l'Association Medicale Canadienne, 171(03):235-239.

Gschwend, P; Rehm, J; Blattler, R; Steffen, T; Seidenberg, A; Christen, S; Burki, C; Gutzwiller, Felix (2004). Dosage regimes in the prescription of heroin and other narcotics to chronic opioid addicts in switzerland – swiss national cohort study. European Addiction Research, 10(1):41-48.

Fischer, B; Haydon, E; Rehm, J; Krajden, M; Reimer, J (2004). Injection drug use and the hepatitis C virus: considerations for a targeted treatment Approach - the case study of Canada. Journal of Urban Health: Bulletin of the New York Academy of Medicine, 81(03):428-447.

Rehm, J; Fischer, B; Haydon, E; Room, R (2003). Abstinence ideology and somatic treatment for addicts - ethical considerations. Editorial. Addiction Research and Theory, 11(5):287-293.

Rehm, J; Sempos, C T; Trevisan, M (2003). Average volume of alcohol consumption, patterns of drinking and risk of coronary heart disease - A review. European Journal of Preventive Cardiology, 10(1):15-20.

Rehm, J (2003). Causal chain analysis: Rehm replies to Finney. Addiction, 98(4):534-535.

Crofts, N (2003). Complacency as a barrier to effective prevention, treatment and policy of HIV/AIDS and IDU. In: Fischer, B; Rehm, J; Haydon, E. Reducing the Risks, Harms and Costs of HIV/AIDS and Injection Drug Use: A Synthesis of the Evidence Base for Development of Policies and Programs. Background paper #4, 2nd Annual Background Dialogue on HIV/AIDS. Warsaw: Health Canada/UNAIDS/Canadian International Development Agency, n/a.

Rehm, J; Fichter, M; Elton, M (2003). Effects on mortality of alcohol consumption, smoking, physical activity, and close personal relationships. Addiction, 88(1):101-112.

Rehm, J (2003). Ein Paradigmenwechsel in der Alkoholforschung. Editorial. Sucht, 49(2):84-85.

Rehm, J (2003). Epidemiologische Grundlagen für Alkoholintervention - ein schweizerischer Beitrag zu 'Alcohol Policy and the Public Good II'. In: Bundesamt für Gesundheit. Suchtforschung des BAG / Recherches de l'OFSP en matière de dépendances 1999-2001. Band 1. Bern: Bundesamt für Gesundheit, 109-111.

Rehm, J (2003). Gesellschaftsreform als soziales Experiment — Ein unzeitgemässes Projekt oder der Ausweg aus erstarrten Sachzwängen in der Alkoholpolitik. Review of R. Room (2002). The effects of Nordic alcohol policies. What happens to drinking and harm when alcohol controls change? Sucht, 49(2):129-130.

Gschwend, P; Rehm, J; Eschmann, S; Uchtenhagen, U (2003). Heroingestützte Behandlung für Opioidabhängige in der Schweiz von 1994-2001 - Inanspruchnahme und Charakteristik der Ein- und Austretenden. Gesundheitswesen (Bundesverband der Ärzte des Öffentlichen Gesundheitsdienstes (Germany)), 65(2):75-80.

Dolan, K (2003). IDU and HIV/AIDS risk reduction, prevention and treatment measures for prison populations. In: Fischer, B; Rehm, J; Haydon, E. Reducing the risks, harms and costs of HIV/AIDS and injecting drug use: a synthesis of the evidence base for development of policies and programs. Ottawa: Health Canada, n/a.

Rehm, J (2003). Ist Suchtprävention generell wirtschaftlich? Suchttherapie, 4(1):8-11.

Rey-Riek, S; Gschwend, P; Eschmann, S; Moldovanyi, A; Rehm, J (2003). Klinisches Monitoring der heroingestützten Behandlung in der Schweiz. In: Bundesamt für Gesundheit. Suchtforschung des BAG / Recherches de l'OFSP en matière de dépendances 1999-2001. Band 1. Bern: Bundesamt für Gesundheit, 58-62.

Rey-Riek, S; Guttinger, F; Rehm, J (2003). Lohnt sich betriebliche Suchtprävention? Zu Effektivität und Effizienz betrieblicher Alkoholprävention. Suchttherapie, 4(1):12-17.

Rehm, J (2003). Mortality and disability due to alcohol consumption. In: Bundesamt für Gesundheit. Suchtforschung des BAG / Recherches de l'OFSP en matière de dépendances 1999-2001. Band 1. Bern: Bundesamt für Gesundheit, 112-114.

Rehm, J (2003). Review of: T. Norström (2002). Alcohol in postwar Europe. Consumption, drinking patterns and policy responses in 15 European countries. Addiction, 98(7):1007-1008.

Rehm, J (2003). Scientific evaluations of opioid-assisted substitution treatment. In: Kuntze, M F; Müller-Spahn, F; Ladewig, D; Bullinger, A H. Basic and clinical science of opioid addiction. Bibliotheca Psychiatrica. Basel: Karger, 33-38.

Fischer, B; Haydon, E; Kim, G; Rehm, J; El-Guebaly, N (2003). Screening for antisocial personality disorder in drug users — A qualitative exploratory study on feasibility. International Journal of Methods in Psychiatric Research, 12(3):151-156.

Haydon, E; Fischer, B; Rehm, J (2003). Social determinants of injection drug use and HIV/AIDS. In: Rehm, J; Fischer, B; Haydon, E. Reducing the risks, harms and costs of HIV/AIDS and injecting drug use: a synthesis of the evidence base for development of policies and programs. Ottawa: s.n., n/a.

Rehm, J (2003). Suchtmittel und Public Health. Suchttherapie, 4(2):72-75.

Strathdee, S (2003). The international epidemiology and burden of disease of injection drug use and HIV/AIDS. In: Rehm, J; Fischer, B; Haydon, E. Reducing the risks, harms and costs of HIV/AIDS and injecting drug use: a synthesis of the evidence base for development of policies and programs. Ottawa: Health Canada, n/a.

Hartwig, C; Lerch, S; Rehm, J; Gschwend, P (2003). Unerwünschte Arzneimittelwirkungen in der Heroin-gestützten Behandlung (HeGeBe) im Zusammenhang mit verschiedenen Applikationsformen in den Jahren 2001-2002. Zurich: Schweizer Institut für Sucht- und Gesundheitsforschung.

Rey-Riek, S; Gschwend, P; Rehm, J (2003). Validität von Selbstangaben zum Drogenkonsum in der heroingestützten Behandlung in der Schweiz. Sucht, 49(1):24-29.

Rehm, J (2003). Zur vergleichenden Bewertung von Interventionen im Bereich Alkohol: Welche Massnahme ist am kosteneffektivsten? In: Bundesamt für Gesundheit. Suchtforschung des BAG / Recherches de l'OFSP en matière de dépendances 1999-2001. Band 1. Bern: Bundesamt für Gesundheit, 115-118.

Rehm, J (2002). Kritische Betrachtungen von Kosten-Nutzen Überlegungen zum Alkohol. In: Enquete Jugend und Alkohol, Bregenz, 12 November 2002 - 12 November 2002, 3-4.

Fischer, B; Brissette, S; Brochu, S; Bruneau, J; El-Guebaly, N; Noel, L; Rehm, J; Tyndall, M (2002). 'OPICAN': a multisite cohort study of untreated illicit opiate users in Canada. Journal of Urban Health: Bulletin of the New York Academy of Medicine, 79(Suppl.1):S69.

Rehm, J (2002). Alkoholkonsum und Gesamtmortalität und Morbidität - Gibt es positive Auswirkungen eines moderaten regelmässigen Alkoholkonsums? In: Singer, M V; Teyssen, S. Alkohol und Alkoholfolgekrankheiten. Grundlagen - Diagnostik - Therapie. Heidelberg: Springer, 447-457.

Rehm, J; Eschmann, S (2002). Global monitoring of average volume of alcohol consumption. Sozial- und Präventivmedizin, 47(1):48-58.

Rehm, J; Fischer, B; Krausz, M (2002). Heroin prescription for opioid addicts. Authors' reply. Lancet, 359(9309):390.

Frei, A; Rehm, J (2002). Komorbidität: psychische Störungen bei Opiatabhängigen zu Beginn einer Heroin gestützten Behandlung. Psychiatrische Praxis, 29(5):251-257.

Rehm, J (2002). Noch ein weiter Weg zu evidenzbasierter Gesundheitspolitik im Bereich Substanzmissbrauch. Sucht, 48(2):133-134.

Rehm, J; Single, E (2002). Reasons for and effects of low risk drinking guidelines. In: Bühringer, G. Strategien und Projekte zur Reduktion alkoholbedingter Störungen. Lengerich: Pabst, 78-90.

Rehm, J (2002). Review of R. Longabaugh & P.W. Wirtz (2001). Project MATCH hypotheses: results and causal chain analyses. Addiction, 97(11):1477-1478.

Fischer, B; Rehm, J; Kim, G; Robins, A (2002). Safer injection facilities (SIFs) for injection drug users (IDUs) in Canada. A review and call for an evidence-focused pilot trial. Canadian Journal of Public Health. Revue Canadienne de Santé Publique, 93(5):336-338.

Rehm, J (2002). The role of consumers. Reflections on the possibilities and limits of user interviews in opiate addiction treatment. Substance Use & Misuse, 37(4):533-536.

Rehm, J; Fischer, B (2002). Von kontrollierten klinischen Studien zu einer Gestaltung des Behandlungssytems für Suchtkranke. Sucht, 48(03):310-311.

Rehm, J; Greenfield, T; Rogers, J D (2001). Average volume of alcohol consumption, patterns of drinking and all-cause mortality. Results from the U.S. National Alcohol Survey. American Journal of Epidemiology, 153(1):64-71.

Fischer, B; Medved, W; Kirst, M; Rehm, J; Gliksman, L (2001). Illicit opiates and crime: Results of an untreated user cohort study in Toronto. Canadian Journal of Criminology and Criminal Justice, 43(02):197-217.

Fischer, B; Rehm, J (2001). Some reflections on the relationship of risk, harm and responsibility in recent tobacco lawsuits, and implications for public health. Canadian Journal of Public Health. Revue Canadienne de Santé Publique, 92(1):7-8.

Rehm, J; Rossow, I (2001). The impact of alcohol consumption on work and education. In: Klingemann, Harald; Gmehl, Gerhard. Mapping social consequences of alcohol consumption. Dordrecht: Kluwer Academic Publishers, 67-77.

Rehm, J; Trotter, R I I; Chatterji, S; Ustun, T (2001). The structure and stability of the proposed international classification. In: Ustun, T; Chatterji, S; Trotter, R I I; Room, J; Rehm, J; Saxena, S. Disability and culture: universalism and diversity. Seattle: Hogrefe and Huber, 293-308.

Rehm, J; Sempos, C; Kohlmeier, L; Myers, G; Thefeld, W; Gunter, E; Thamm, M; Dortschy, R; Murphy, R; Feinlieb, M; Hoffmeister, H (2000). A comparison of serum total cholestrol levels and their determinants between the Federal Republic of Germany and the United States. European Journal of Epidemiology, 16(7):669-675.

Rehm, J (2000). Alcohol consumption and mortality. What do we know and where should we go? Addiction, 95(7):989-995.

Rehm, J; Ferrence, R; Cohen, J; Gucciardi, E (2000). Cigarette price and smoking behaviours in Canadian provinces: a longitudinal analysis. Toronto: OTRU.

Rehm, J; Fischer, B (2000). Heroingestützte Therapie für Opiatabhängige - weder Allheilmittel noch Teufelswerk. Suchttherapie, 01(02):57-62.

Fischer, B; Rehm, J; Blitz-Miller, T (2000). Injection drug use and preventive measures: A comparison of Canadian and Western European jurisdictions over time. Canadian Medical Association Journal = Journal de l'Association Medicale Canadienne, 162(12):1709-1713.

Rehm, J; Fischer, B (2000). Kosten, Nutzen und Effizienz der Opiatsubstitution. In: Zerdick, J. Suchtmedizin im Dialog. Berlin: Verlag für Wissenschaft und Bildung, 71-78.

Rehm, J; Bondy, S (2000). Moderater Alkoholkonsum und Morbidität und Mortalität bei Verdauungskrankheiten. Verdauungskrankheiten 4, University of Zurich.

Rehm, J (2000). Review of: I. Maltzman (2000). Alcoholism. A review of its characteristics, etiology, treatments and controversies. Open Addiction Journal, 95(9):1444-1445.

Wall, R; Rehm, J; Fischer, B; Brands, B; Gliksman, L; Stewart, J; Medved, W; Blake, J (2000). Social costs of untreated opioid dependence. Journal of Urban Health: Bulletin of the New York Academy of Medicine, 77(4):688-722.

Fischer, B; Kirst, M; Rehm, J; Marsh, D; Bondy, S; Tyndall, M (2000). The phenomenon of so-called 'other drug use' among opiate addicts in the North American context: Evidence, consequences, questions. In: Jellinek, C; Westermann, B; Bellmann, G. Beigebrauch: Offene Grenzen der Substitution. Weinheim: Deutscher Studienverlag, 95-117.

Fischer, B; Rehm, J (1999). Argumentos a favor de un ensayo de tratamiento de sustitución con heroína en Canadá. In: Inchaurraga, S. Drogas y políticas públicas : El modelo de la reducción de daños Drugs and public policies: The 'harm reduction' model. Rosario: Universidad de Rosario, 105-117.

Fischer, B; Gliksman, L; Rehm, J; Daniel, N; Medved, W (1999). Comparing opiate users in methadone treatment with untreated opiate users: results of a follow-up study with a Toronto opiate user cohort. Canadian Journal of Public Health. Revue Canadienne de Santé Publique, 90(5):299-303.

Fischer, B; Medved, W; Gliksman, L; Rehm, J (1999). Illicit opiates in Toronto: a profile of current users. European Addiction Research, 7(5):377-415.

Fischer, B; Rehm, J (1996). Alcohol consumption and the liability of offenders in the German criminal system. Contemporary Drug Problems, 23(Winter):707-729.

This list was generated on Mon Jul 24 04:02:52 2017 CEST.